West Nile virus neuroinvasive disease: Neurological manifestations and prospective longitudinal outcomes

John Hart, Gail Tillman, Michael A. Kraut, Hsueh Sheng Chiang, Jeremy F. Strain, Yufeng Li, Amy G. Agrawal, Penny Jester, John W. Gnann, Richard J. Whitley

Research output: Contribution to journalArticle

46 Citations (Scopus)

Abstract

Background: West Nile Virus (WNV) is a mosquito-borne flavivirus that has caused ongoing seasonal epidemics in the United States since 1999. It is estimated that ≤1% of WNV-infected patients will develop neuroinvasive disease (West Nile encephalitis and/or myelitis) that can result in debilitating morbidities and long-term sequelae. It is essential to collect longitudinal information about the recovery process and to characterize predicative factors that may assist in therapeutic decision-making in the future.Methods: We report a longitudinal study of the neurological outcomes (as measured by neurological examination, Glascow Coma Scale, and Modified Mini-Mental State Examination) for 55 subjects with WNV neuroinvasive disease (confirmed by positive CSF IgM) assessed on day 7, at discharge, and on days 14, 30, and 90. The neurological outcome measures were coma (presence and degree), global cognitive status, presence of cranial neuropathy, tremors and/or weakness.Results: At initial clinical presentation 93% presented with a significant neurological deficit (49% with weakness, 35% with tremor, and 16% with cranial neuropathy). The number of patients with a cognitive deficit fell from 25 at initial evaluation to 9 at their last evaluation. Cranial neuropathy was present in 9 at onset and in only 4 patients at study conclusion. Of the 19 patients who had a tremor at enrollment, 11 continued to exhibit a tremor at follow-up. Seven patients died after initial enrollment in the study, with 5 of those having presented in a coma. The factors that predict either severity or long-term recovery of neurological function include age (older individuals were weaker at follow-up examination), gender (males recovered better from coma), and presentation in a coma with cranial nerve deficits (had a poorer recovery particularly with regard to cognition).Conclusions: This study represents one of the largest clinical investigations providing prospectively-acquired neurological outcomes data among American patients with WNV central nervous system disease. The findings show that the factors that influence prognosis from the initial presentation include age, gender, and specific neurological deficits at onset.Trial registration: ClinicalTrials.gov identifier: NCT00138463 and NCT00069316.

Original languageEnglish (US)
Article number248
JournalBMC Infectious Diseases
Volume14
Issue number1
DOIs
StatePublished - May 9 2014

Fingerprint

West Nile virus
Virus Diseases
Neurologic Manifestations
Coma
Tremor
Cranial Nerve Diseases
Myelitis
Flavivirus
Cranial Nerves
Central Nervous System Diseases
Recovery of Function
Neurologic Examination
Encephalitis
Culicidae
Cognition
Immunoglobulin M
Longitudinal Studies
Decision Making
Outcome Assessment (Health Care)
Morbidity

Keywords

  • 3MS
  • Coma
  • Encephalitis
  • Neurological deficit
  • West Nile virus

ASJC Scopus subject areas

  • Infectious Diseases
  • Medicine(all)

Cite this

West Nile virus neuroinvasive disease : Neurological manifestations and prospective longitudinal outcomes. / Hart, John; Tillman, Gail; Kraut, Michael A.; Chiang, Hsueh Sheng; Strain, Jeremy F.; Li, Yufeng; Agrawal, Amy G.; Jester, Penny; Gnann, John W.; Whitley, Richard J.

In: BMC Infectious Diseases, Vol. 14, No. 1, 248, 09.05.2014.

Research output: Contribution to journalArticle

Hart, J, Tillman, G, Kraut, MA, Chiang, HS, Strain, JF, Li, Y, Agrawal, AG, Jester, P, Gnann, JW & Whitley, RJ 2014, 'West Nile virus neuroinvasive disease: Neurological manifestations and prospective longitudinal outcomes', BMC Infectious Diseases, vol. 14, no. 1, 248. https://doi.org/10.1186/1471-2334-14-248
Hart, John ; Tillman, Gail ; Kraut, Michael A. ; Chiang, Hsueh Sheng ; Strain, Jeremy F. ; Li, Yufeng ; Agrawal, Amy G. ; Jester, Penny ; Gnann, John W. ; Whitley, Richard J. / West Nile virus neuroinvasive disease : Neurological manifestations and prospective longitudinal outcomes. In: BMC Infectious Diseases. 2014 ; Vol. 14, No. 1.
@article{3ed37658a14c49dab42e04c2d2a8350e,
title = "West Nile virus neuroinvasive disease: Neurological manifestations and prospective longitudinal outcomes",
abstract = "Background: West Nile Virus (WNV) is a mosquito-borne flavivirus that has caused ongoing seasonal epidemics in the United States since 1999. It is estimated that ≤1{\%} of WNV-infected patients will develop neuroinvasive disease (West Nile encephalitis and/or myelitis) that can result in debilitating morbidities and long-term sequelae. It is essential to collect longitudinal information about the recovery process and to characterize predicative factors that may assist in therapeutic decision-making in the future.Methods: We report a longitudinal study of the neurological outcomes (as measured by neurological examination, Glascow Coma Scale, and Modified Mini-Mental State Examination) for 55 subjects with WNV neuroinvasive disease (confirmed by positive CSF IgM) assessed on day 7, at discharge, and on days 14, 30, and 90. The neurological outcome measures were coma (presence and degree), global cognitive status, presence of cranial neuropathy, tremors and/or weakness.Results: At initial clinical presentation 93{\%} presented with a significant neurological deficit (49{\%} with weakness, 35{\%} with tremor, and 16{\%} with cranial neuropathy). The number of patients with a cognitive deficit fell from 25 at initial evaluation to 9 at their last evaluation. Cranial neuropathy was present in 9 at onset and in only 4 patients at study conclusion. Of the 19 patients who had a tremor at enrollment, 11 continued to exhibit a tremor at follow-up. Seven patients died after initial enrollment in the study, with 5 of those having presented in a coma. The factors that predict either severity or long-term recovery of neurological function include age (older individuals were weaker at follow-up examination), gender (males recovered better from coma), and presentation in a coma with cranial nerve deficits (had a poorer recovery particularly with regard to cognition).Conclusions: This study represents one of the largest clinical investigations providing prospectively-acquired neurological outcomes data among American patients with WNV central nervous system disease. The findings show that the factors that influence prognosis from the initial presentation include age, gender, and specific neurological deficits at onset.Trial registration: ClinicalTrials.gov identifier: NCT00138463 and NCT00069316.",
keywords = "3MS, Coma, Encephalitis, Neurological deficit, West Nile virus",
author = "John Hart and Gail Tillman and Kraut, {Michael A.} and Chiang, {Hsueh Sheng} and Strain, {Jeremy F.} and Yufeng Li and Agrawal, {Amy G.} and Penny Jester and Gnann, {John W.} and Whitley, {Richard J.}",
year = "2014",
month = "5",
day = "9",
doi = "10.1186/1471-2334-14-248",
language = "English (US)",
volume = "14",
journal = "BMC Infectious Diseases",
issn = "1471-2334",
publisher = "BioMed Central",
number = "1",

}

TY - JOUR

T1 - West Nile virus neuroinvasive disease

T2 - Neurological manifestations and prospective longitudinal outcomes

AU - Hart, John

AU - Tillman, Gail

AU - Kraut, Michael A.

AU - Chiang, Hsueh Sheng

AU - Strain, Jeremy F.

AU - Li, Yufeng

AU - Agrawal, Amy G.

AU - Jester, Penny

AU - Gnann, John W.

AU - Whitley, Richard J.

PY - 2014/5/9

Y1 - 2014/5/9

N2 - Background: West Nile Virus (WNV) is a mosquito-borne flavivirus that has caused ongoing seasonal epidemics in the United States since 1999. It is estimated that ≤1% of WNV-infected patients will develop neuroinvasive disease (West Nile encephalitis and/or myelitis) that can result in debilitating morbidities and long-term sequelae. It is essential to collect longitudinal information about the recovery process and to characterize predicative factors that may assist in therapeutic decision-making in the future.Methods: We report a longitudinal study of the neurological outcomes (as measured by neurological examination, Glascow Coma Scale, and Modified Mini-Mental State Examination) for 55 subjects with WNV neuroinvasive disease (confirmed by positive CSF IgM) assessed on day 7, at discharge, and on days 14, 30, and 90. The neurological outcome measures were coma (presence and degree), global cognitive status, presence of cranial neuropathy, tremors and/or weakness.Results: At initial clinical presentation 93% presented with a significant neurological deficit (49% with weakness, 35% with tremor, and 16% with cranial neuropathy). The number of patients with a cognitive deficit fell from 25 at initial evaluation to 9 at their last evaluation. Cranial neuropathy was present in 9 at onset and in only 4 patients at study conclusion. Of the 19 patients who had a tremor at enrollment, 11 continued to exhibit a tremor at follow-up. Seven patients died after initial enrollment in the study, with 5 of those having presented in a coma. The factors that predict either severity or long-term recovery of neurological function include age (older individuals were weaker at follow-up examination), gender (males recovered better from coma), and presentation in a coma with cranial nerve deficits (had a poorer recovery particularly with regard to cognition).Conclusions: This study represents one of the largest clinical investigations providing prospectively-acquired neurological outcomes data among American patients with WNV central nervous system disease. The findings show that the factors that influence prognosis from the initial presentation include age, gender, and specific neurological deficits at onset.Trial registration: ClinicalTrials.gov identifier: NCT00138463 and NCT00069316.

AB - Background: West Nile Virus (WNV) is a mosquito-borne flavivirus that has caused ongoing seasonal epidemics in the United States since 1999. It is estimated that ≤1% of WNV-infected patients will develop neuroinvasive disease (West Nile encephalitis and/or myelitis) that can result in debilitating morbidities and long-term sequelae. It is essential to collect longitudinal information about the recovery process and to characterize predicative factors that may assist in therapeutic decision-making in the future.Methods: We report a longitudinal study of the neurological outcomes (as measured by neurological examination, Glascow Coma Scale, and Modified Mini-Mental State Examination) for 55 subjects with WNV neuroinvasive disease (confirmed by positive CSF IgM) assessed on day 7, at discharge, and on days 14, 30, and 90. The neurological outcome measures were coma (presence and degree), global cognitive status, presence of cranial neuropathy, tremors and/or weakness.Results: At initial clinical presentation 93% presented with a significant neurological deficit (49% with weakness, 35% with tremor, and 16% with cranial neuropathy). The number of patients with a cognitive deficit fell from 25 at initial evaluation to 9 at their last evaluation. Cranial neuropathy was present in 9 at onset and in only 4 patients at study conclusion. Of the 19 patients who had a tremor at enrollment, 11 continued to exhibit a tremor at follow-up. Seven patients died after initial enrollment in the study, with 5 of those having presented in a coma. The factors that predict either severity or long-term recovery of neurological function include age (older individuals were weaker at follow-up examination), gender (males recovered better from coma), and presentation in a coma with cranial nerve deficits (had a poorer recovery particularly with regard to cognition).Conclusions: This study represents one of the largest clinical investigations providing prospectively-acquired neurological outcomes data among American patients with WNV central nervous system disease. The findings show that the factors that influence prognosis from the initial presentation include age, gender, and specific neurological deficits at onset.Trial registration: ClinicalTrials.gov identifier: NCT00138463 and NCT00069316.

KW - 3MS

KW - Coma

KW - Encephalitis

KW - Neurological deficit

KW - West Nile virus

UR - http://www.scopus.com/inward/record.url?scp=84900495450&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84900495450&partnerID=8YFLogxK

U2 - 10.1186/1471-2334-14-248

DO - 10.1186/1471-2334-14-248

M3 - Article

C2 - 24884681

AN - SCOPUS:84900495450

VL - 14

JO - BMC Infectious Diseases

JF - BMC Infectious Diseases

SN - 1471-2334

IS - 1

M1 - 248

ER -